Technology · Semiconductors · Synthos Deep Dive · 2026-07-03
| Verdict | Hold — systematic Synthos tier |
| Price (2026-07-02) | $293.08 · market cap ~$267B |
| Synthos scores (0–10) | Downside Risk 6 · Growth Quality 6 · Exponential Potential 4 |
| Synthos fair value (base case) | ~$270 → −8% · full range $175 (bear) – $360 (bull) |
| Street consensus | $281.56 (high $400 / low $175; 31 Buy · 27 Hold · 7 Sell) — context, not our anchor |
| Valuation | ~50× trailing EPS · 38× FY26E · 33× FY27E · 24× FY30E · EV/S 15.0× · EV/EBITDA 31× |
| Exponential Potential | 4/10 · Low-Moderate — durable analog compounder recovering off a cyclical trough, but ~12% revenue CAGR and mature end-markets cap the multibagger |
| Technicals | Neutral-to-up — $293, −12% off 52-wk high, above 200-DMA / at 50-DMA, RSI 49, +39% 12-mo (SPY +21%) |
| Conviction | Low — 1 net-bullish voice (Jordi Visser, conviction 82), 1 reconciled claim; this is a quant/index-track note |
| Position sizing | Satellite-at-most, ≤2% — and only on a pullback; not a buy here |
| Next catalyst | 2026-07-22 Q2'26 earnings (Street EPS $1.90, revenue ~$5.23B) |
| Single biggest risk | Paying a peak multiple on trough earnings — a slower analog recovery re-rates the stock down |
One-line thesis. Texas Instruments is one of the highest-quality franchises in all of semis — 57% gross margin, 32% ROE, a fortress distribution moat in analog/embedded chips — but after a +39% twelve-month run it trades at ~50× trailing and ~38× forward earnings while free cash flow is still squeezed by a historic capex build; the quality is real, the entry price is not, so we Watch.
Texas Instruments makes the small, unglamorous analog and embedded chips that go inside almost every electronic device — cars, factory equipment, appliances, phones. They don't make the flashy AI chips (that's Nvidia); they make the "boring" power-management and sensor chips that every gadget needs. It's an extremely profitable, well-run company: it keeps about 29 cents of every sales dollar as profit and has paid and raised its dividend for over 20 years.
The catch: the stock is expensive right now. Its chip business runs in cycles, and earnings are just recovering from a downturn — so you're paying a high price (about 50× last year's earnings) at a moment when profits are near a low point. That combination is what keeps us cautious. Our verdict is Watch — a great company worth owning, but wait for a better price.
Here's what our three scores mean in everyday terms:
The one big worry: you're paying a premium price on earnings that are near the bottom of the chip cycle. If the recovery is slower than hoped, the stock could fall meaningfully.
Solid = price · dashed = 50-day average · dotted = 200-day average · amber = 52-week high/low. Price above both averages is an uptrend.
The shaded band widens when the stock gets more volatile. Riding the upper edge = strong momentum (sometimes stretched); the lower edge = weak / potentially oversold.
Above 70 (red band) = overbought, below 30 (green band) = oversold. Currently 48.
Blue crossing above amber (bars flip green) = momentum turning up; below (bars red) = turning down. Bar height = the size of that gap.
Solid = TXN · dashed = S&P 500 · dotted = XLK (sector). A rising line means it is beating that benchmark — the sector line shows whether it is a leader or laggard within its own group.
Darker bars = actual results, brighter = analyst estimates. Taller bars to the right = expected growth.
“Edge AI (autos, phones, computers, humanoids) is coming and needs different power semiconductors; power semis are the next leg of the thesis.”
Every claim reconciles to a real claim_id in the Synthos knowledge base — this is the evidence the verdict is built on, not vibes. Management (the company itself) is shown but half-weighted; one cautionary voice is included on purpose.
Texas Instruments (Nasdaq: TXN), founded 1930 and headquartered in Dallas, is the world's largest maker of analog and embedded processing semiconductors — the power-management chips, amplifiers, data converters, interface devices, sensors, and microcontrollers that go into virtually every piece of electronic equipment. Its edge is not any single chip but the breadth of catalog (~80,000 products), the depth of its direct-sales/distribution reach, and 300mm in-house wafer manufacturing that structurally lowers unit cost. CEO Haviv Ilan. Fiscal year ends December 31.
Revenue mix (FY2025, from filings):
The forward story management and the lone bullish voice keep returning to: more electronic content per device (especially autos and industrial automation), and — per Jordi Visser — a new leg from edge-AI power semiconductors as AI moves into phones, PCs, cars and humanoid robots.
Synthos KB coverage on TXN is thin: 1 traceable claim, 1 net-bullish voice, net conviction +82. This is a quant/index-track note, not a high-conviction panel call — the verdict below is driven by fundamentals and valuation, not by a broad expert consensus. We say that plainly.
The one voice on file:
jordi_visser-EetiLq26uio:e9a5ae42ad): "Edge AI (autos, phones, computers, humanoids) is coming and needs different power semiconductors; power semis are the next leg of the thesis." This is a structural, forward thesis — it argues the next AI wave shows up not just in GPUs but in the analog/power content TXN dominates. It is directionally supportive of the franchise but it is (a) a single voice and (b) a multi-year, non-catalyst thesis, so we treat it as optionality, not an anchor.Honest composite note. With only one claim there is no breadth to lean on and no cautionary counter-voice in the KB — so we supply the caution ourselves from the numbers: a ~50× trailing multiple on trough earnings, a still-squeezed FCF line, and 21% China exposure. A single high-skill bullish claim is a reason to keep TXN on the radar, not a reason to buy it here.
The one-glance judgment — three scores, 0–10, each anchored to real metrics (not probabilities we can't honestly calibrate):
| Score | 0–10 | The read |
|---|---|---|
| Downside Risk (lower = safer) | 6 · Moderate-High | Investment-grade balance sheet and net-debt/EBITDA ~1.2× are reassuring, but ~50× trailing EPS on trough earnings, beta 1.31, deep semiconductor cyclicality and ~21% China revenue all cut the other way. |
| Growth Quality | 6 · Good | 57% gross margin, 32% ROE, 18% ROIC, and a ~17% forward EPS CAGR are high-quality — but revenue only compounds ~12%, and heavy capex holds FCF conversion down (FCF was just $2.6B on $5.0B net income in FY25). |
| Exponential Potential | 4 · Low-Moderate | A durable analog compounder, not an exponential: ~12% revenue CAGR into mature auto/industrial end-markets, a $267B cap, and growth that is recovering (not accelerating structurally). Edge-AI/power is real optionality but unproven in the numbers. |
The three cases (our own scenario model — assumptions shown; each target is a ~12–18-month fair value). We deliberately do not attach probabilities: the base case is by definition the expected path, so a weighted blend would just restate it with false precision. Instead the cases bound the range, and the scores above summarize them.
| Case | Key assumptions | Fair value |
|---|---|---|
| Bull | Cyclical recovery accelerates; industrial/auto content and Visser's edge-AI power leg both land; capex rolls off and FCF inflects hard. FY27E EPS beats to ~$10 (vs $8.95 cons); market pays a premium ~36×. | ~$360 (+23%) |
| Base (our anchor) | Estimates roughly hit — FY27E EPS ~$8.95; a high-quality but cyclical analog leader earns a ~30× through-cycle multiple. | ~$270 (−8%) |
| Bear | Recovery stalls, China/industrial demand disappoints, capex keeps FCF suppressed; the market treats current EPS as near-peak. FY27E EPS misses to ~$7; multiple de-rates to ~25×. | ~$175 (−40%) |
Synthos fair value = the base case, ~$270 (−8%), with the full $175–$360 span as the honest range. Our base sits just below today's $293 and essentially at the Street's $281.56 consensus — the takeaway is that TXN is fairly-to-fully valued here, which is exactly why the verdict is Watch rather than Buy. Notably the Street's own low target ($175) equals our bear, underscoring how much cyclical downside the multiple leaves exposed. This is a tracked call — the Forecaster Scorecard grades it once it matures.
Synthos separates compounders (durable high returns on capital) from exponentials (accelerating, multi-baggers-from-here). TXN is a classic high-quality compounder — decidedly not an exponential:
jordi_visser-EetiLq26uio:e9a5ae42ad) is the one credible path to acceleration — if AI at the edge lifts power-semi content per device materially. It is unproven in the numbers today, so we credit it as upside, not base.Exponential Potential: Low-Moderate (4/10). Own TXN, if at all, for durable ~15% earnings compounding, an elite dividend record and a fortress moat — not for a fast multibagger.
There is no way to call TXN cheap: ~50× trailing EPS, 15× sales, 31× EV/EBITDA, and a 1.4% free-cash-flow yield. FMP's own letter grade is B (overall 3/5), dragged down by a P/E score of 2 and debt-to-equity score of 1. The bull's defense is the same as always for a cyclical: trailing earnings are at a trough, so the multiple overstates the richness. On forward consensus the P/E compresses to 38× (FY26E) → 33× (FY27E) → 24× (FY30E) — real compression, but the stock is still not obviously cheap even four years out. A through-cycle earnings view (call it ~$8–9 of normalized EPS) at a fair ~30× lands near $255–$270, essentially today's price. Street targets (context): consensus $281.56, median $300, high $400, low $175 — an unusually wide band (31 Buy / 27 Hold / 7 Sell) that itself signals a fully-valued, debate-worthy setup. Our ~$270 base is deliberately at the conservative end. Not a value buy; a quality-at-a-full-price name to watch.
TXN's moat is a rare combination for a chipmaker: (1) catalog breadth — ~80,000 analog/embedded parts sold to ~100,000 customers, so no single customer or design win dominates and demand is extraordinarily diversified; (2) cost leadership from in-house 300mm manufacturing — TXN makes its own wafers at a structurally lower cost than fabless analog peers, the source of its 57%+ gross margin; (3) a direct sales + distribution reach that compounds design-win stickiness over decades-long product lifecycles. The current fab buildout is a deliberate widening of moat (2). The threats are cyclicality, China competition and demand (~21% of revenue), and the risk that the capex bet depresses returns for longer than expected.
Peer set (market cap): Analog Devices $184B (the closest analog comp), Broadcom $1.71T, AMD $844B, Micron $1.10T, Intel $605B, Marvell $215B, Qualcomm $186B, NXP $69B, Microchip $46B, ON Semi $36B, Monolithic Power $63B, Lattice $19B, Qorvo $8B. Against ADI — the truest comparable — TXN is larger, more vertically integrated, and richer-margin; against the AI-levered names (AVGO, AMD, MU) TXN offers far less growth but far more stability and a better dividend.
jordi_visser-EetiLq26uio:e9a5ae42ad).Thesis tripwires (what would change the call): two consecutive quarters of stalled revenue recovery or falling gross margin; FCF failing to inflect as capex is guided lower; or a multiple that re-rates below ~25× FY27E (toward our bear) — at which point Watch could flip to Buy on price.
Watch. Texas Instruments is a genuinely elite franchise — 57% gross margin, 32% ROE, a fortress analog moat, and a decades-long dividend record — and the earnings recovery off the 2024 trough is real (Q1'26 EPS +32% YoY). But quality is not the question; price is. At ~$293 the stock trades ~50× trailing and ~38× forward earnings with a 1.4% FCF yield, our base-case fair value (~$270) sits below the current price, and the Street's own low target ($175) matches our bear — the risk/reward is simply not compelling here. The lone bullish expert voice (Visser's edge-AI/power thesis) is a reason to keep TXN on the watchlist, not to pay this multiple today.
claim_id (cited inline). This is a quant/index-track note; the verdict is fundamentals- and valuation-driven, not a broad expert-panel call. Fabricated conviction is structurally impossible (claim-ID reconciliation).